Moderna Swings to Q3 Earnings, Revenue Rise; Raises 2026 Revenue Guidance -- Shares Rise Pre-Bell

07:06 AM EST, 11/06/2026 (MT Newswires) -- Moderna (MRNA) reported Q3 earnings Friday of $0.38 per share, swinging from a loss of $0.51 a year earlier. Analysts polled by FactSet expected a loss of $1.13. Revenue for the quarter ended Sept. 30 was $1.31 billion, compared with $1.02 billion a year earlier. Analysts expected $890.3 million. For 2026, the company now expects revenue growth of 15% to 25%, compared with its prior growth guidance of up to 10%. Analysts are looking for $2.10 billion. Shares of the company were up 8% in Friday premarket trading.